Search Results 181-190 of 17575 for cannabis

  1. Alprazolam (oral route) - Side effects & dosage - Mayo Clinic

    Cannabis; Carbamazepine; Carbidopa; Carbinoxamine; Carisoprodol; Carphenazine; Cetirizine; Chloral Hydrate; Chlordiazepoxide; Chlorpromazine; Chlorzoxazone ...

  2. Bhanu Kolla, M.D. - Doctors and Medical Staff - Mayo Clinic

    Bhanu Kolla, M.D., MRCPsych, is a psychiatrist with specialty training in sleep medicine and addiction psychiatry. He works both at the center for sleep ...

  3. A Study to Evaluate Safety and Effectiveness of SHP647 as Induction Therapy in Participants with Moderate-to- Severe Crohn's Disease - Mayo Clinic

    ... (cannabis). Subjects with any other severe acute or chronic medical or psychiatric condition or laboratory or electrocardiogram (ECG) abnormality that may ...

  4. A Study to Investigate LP352 in Children and Adults With Developmental and Epileptic Encephalopathies (DEE) - Mayo Clinic

    * The participant has used of any cannabis product or cannabidiol that is not in oral solution/capsule/tablet form, not obtained from a government-approved ...

  5. Mayo Clinic Q and A: Vaping and teens

    Many teens are taking things a step further, adding cannabis, CBD oils and other dangerous additives to vaping devices. When patients show up to the ...

  6. https://www.mayoclinic.org/spanish_patient_consumer_recipe.xml

  7. A Study of BHV-3241 in Subjects with Multiple System Atrophy - Mayo Clinic

    Note: urine drug screen positive for cannabis is exclusionary unless the Investigator and Medical Monitor agree that the subject can abstain from use for ...

  8. A Study of the Efficacy and Safety of Upadacitinib (ABT-494) in Subjects With Moderately to Severely Active Crohn's Disease Who Have Inadequately Responded to or Are Intolerant to Conventional Therapies But Have Not Failed Biologic Therapy - Mayo Clinic

    Subject has cannabis use either recreational or for medical reasons within 14 days prior to Baseline or any history of clinically significant (per ...

  9. Intravenous Ketamine For Treatment-Resistant Depression - Mayo Clinic

    * Use of methamphetamine, cocaine, or cannabis. Abuse of stimulant (s) within the prior 12 months * Any current substance use disorder (excluding nicotine ...

  10. A Study of BHV-3241 in Subjects with Multiple System Atrophy - Mayo Clinic

    Note: urine drug screen positive for cannabis is exclusionary unless the Investigator and. Medical Monitor agree that the subject can abstain from use for ...